{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:44:20Z","timestamp":1785793460556,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijgc.2026.104728","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T23:57:32Z","timestamp":1777161452000},"page":"104728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapy with a levonorgestrel-releasing intra-uterine system in atypical endometrial hyperplasia and low-grade endometrial cancer"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3824-3074","authenticated-orcid":false,"given":"Camila","family":"Mariani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Martin","family":"Lorente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8770-4433","authenticated-orcid":false,"given":"Javier","family":"Frau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9462-9014","authenticated-orcid":false,"given":"Mariela","family":"Orti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ciarmatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4625-3284","authenticated-orcid":false,"given":"Diego","family":"Odetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijgc.2026.104728_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ygyno.2014.10.008","article-title":"Clinically significant endometrial cancer risk following a diagnosis of complex atypical hyperplasia","volume":"135","author":"Costales","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104728_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104728_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232231","article-title":"Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: a systematic review and meta-analysis","volume":"15","author":"Doherty","year":"2020","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.ijgc.2026.104728_bib4","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.3390\/diagnostics14222471","article-title":"Endometrial atypical hyperplasia and risk of endometrial cancer","volume":"14","author":"Chou","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104728_bib5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ijgc.2026.104728_bib6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.17772\/gp\/57813","article-title":"Concurrent endometrial carcinoma in hysterectomy specimens in patients with histopathological diagnosis of endometrial hyperplasia in curettage specimens","volume":"86","author":"Dolanbay","year":"2015","journal-title":"Ginekol Pol"},{"key":"10.1016\/j.ijgc.2026.104728_bib7","doi-asserted-by":"crossref","unstructured":"Management of endometrial hyperplasia (Green-top Guideline no. 67). Royal College of Obstetricians and Gynaecologists. Accessed October 26, 2025. https:\/\/www.rcog.org.uk\/guidance\/browse-all-guidance\/green-top-guidelines\/management-of-endometrial-hyperplasia-green-top-guideline-no-67\/.","DOI":"10.1201\/9781003648543-13"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104728_bib8","doi-asserted-by":"crossref","first-page":"191.e1","DOI":"10.1016\/j.ajog.2020.08.032","article-title":"Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer","volume":"224","author":"Westin","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104728_bib9","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.3390\/ijms23052531","article-title":"Fertility-sparing approaches in atypical endometrial hyperplasia and endometrial cancer patients: current evidence and future directions","volume":"23","author":"Contreras","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104728_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5468\/ogs.19169","article-title":"Fertility-sparing treatment in early endometrial cancer: current state and future strategies","volume":"63","author":"Obermair","year":"2020","journal-title":"Obstet Gynecol Sci"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104728_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/ijgc-2020-001783","article-title":"Fertility considerations prior to conservative management of gynecologic cancers","volume":"31","author":"Stewart","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104728_bib12","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jmig.2017.07.022","article-title":"Updates on conservative management of endometrial cancer","volume":"25","author":"Corzo","year":"2018","journal-title":"J Minim Invasive Gynecol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104728_bib13","doi-asserted-by":"crossref","first-page":"266.e1","DOI":"10.1016\/j.ajog.2012.08.011","article-title":"Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis","volume":"207","author":"Gallos","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104728_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ijgo.12882","article-title":"A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma","volume":"146","author":"Guillon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104728_bib15","article-title":"Levonorgestrel-releasing intrauterine system for endometrial hyperplasia","volume":"9","author":"Mittermeier","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104728_bib16","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.3802\/jgo.2023.34.e85","article-title":"FIGO staging of endometrial cancer: 2023","volume":"34","author":"Berek","year":"2023","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104728_bib17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","article-title":"Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology, NCCN clinical practice guidelines","volume":"16","author":"Koh","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104728_bib18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/ijgc-2022-004047","article-title":"ESGO\/ESHRE\/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma","volume":"33","author":"Rodolakis","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijgc.2026.104728_bib19","article-title":"International ethical guidelines for health-related research involving humans","year":"2016","journal-title":"Council for International Organizations of Medical Sciences (CIOMS)"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104728_bib20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/AOG.0000000000005297","article-title":"Management of endometrial intraepithelial neoplasia or atypical endometrial hyperplasia: ACOG clinical consensus No. 5","volume":"142","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104728_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3892\/ol.2022.13638","article-title":"Use of clinicopathological factors to predict prognosis of fertility-sparing treatment for endometrial endometrioid carcinoma and atypical hyperplasia","volume":"25","author":"Zhang","year":"2022","journal-title":"Oncol Lett."},{"issue":"11","key":"10.1016\/j.ijgc.2026.104728_bib22","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1007\/s43032-022-00982-3","article-title":"Endometrial cancer following levonorgestrel-releasing intrauterine system insertion in young women with atypical hyperplasia: two case reports and literature review","volume":"29","author":"Peng","year":"2022","journal-title":"Reprod Sci"},{"issue":"12","key":"10.1016\/j.ijgc.2026.104728_bib27","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1034\/j.1600-0412.2001.801210.x","article-title":"Dilatation and curettage fails to detect most focal lesions in the uterine cavity in women with postmenopausal bleeding","volume":"80","author":"Epstein","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104728_bib28","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3390\/diagnostics13091567","article-title":"Using the finite element method to determine the odonto-periodontal stress for a patient with angle Class II Division 1 malocclusion","volume":"13","author":"Katta","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"13","key":"10.1016\/j.ijgc.2026.104728_bib29","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.288.13.1610","article-title":"Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review","volume":"288","author":"Clark","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104728_bib30","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.3802\/jgo.2024.35.e27","article-title":"Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia","volume":"35","author":"Lv","year":"2024","journal-title":"J Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26002598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26002598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:47:28Z","timestamp":1785790048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X26002598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1048891X26002598"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104728","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapy with a levonorgestrel-releasing intra-uterine system in atypical endometrial hyperplasia and low-grade endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of European Society of Gynaecological Oncology and the International Gynecologic Cancer Society.","name":"copyright","label":"Copyright"}],"article-number":"104728"}}